ZEB1 and breast cancer: A recent study showed that the expression of miR-200b, which targets both ZEB1 and ZEB2, was downregulated in the cells that undergo TGF-beta-induced epithelial to mesenchymal transition (EMT), and was lost in invasive breast cancer cells [24].